Drug Shortage Report for RECTOGEL HC
| Report ID | 1584 |
| Drug Identification Number | 00662461 |
| Brand name | RECTOGEL HC |
| Common or Proper name | Hydrocortisone acetate, zinc sulfate and benzocaine ointment |
| Company Name | LABORATOIRE RIVA INC. |
| Market Status | DORMANT |
| Active Ingredient(s) | HYDROCORTISONE ACETATE ZINC SULFATE BENZOCAINE |
| Strength(s) | 1.0% 0.5% 10% |
| Dosage form(s) | OINTMENT |
| Route of administration | RECTAL |
| Packaging size | 15g & 30 g |
| ATC code | C05AA |
| ATC description | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2014-04-11 |
| Actual start date | 2014-04-11 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2017-10-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2017-03-13 | French | Compare |
| v2 | 2017-03-13 | English | Compare |
| v1 | 2017-03-13 | English | Compare |
Showing 1 to 3 of 3